iLirafugratinib; RLY-4008

Igama leMchiza:

N-[4-(4-amino-5-{3-fluoro-4-[(4-methylpyrimidin-2-yl)oxy]phenyl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin- 6-yl)phenyl]-2-methylprop-2-enamide

Ikhowudi yoncumo:

C=C(C)C(NC1=CC=C(C2=C(C3=CC=C(OC4=NC=CC(C)=N4)C(F)=C3)C5=C(N)N= CN=C5N2C)C=C1)=O

Ikhowudi ye-InChi:

InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26( 23)36(24 )4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H, 35,37)(H2,30,32,33)

Isitshixo se-InChi:

XOQVZSSDIQQUGO-UHFFFAOYSA-N

Igama elingundoqo:

2549174-42-5; CAS:2549174-42-5;CAS:2549174-42-5;Lirafugratinib; I-RLY-4008; RLY 4008; RLY4008

Ukunyibilika: 

Ugcino:Yomile, emnyama kunye ne-0 - 4 C kwixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).

Inkcazo:

I-Lirafugratinib (RLY-4008) iyasebenza ngomlomo, ayinakuguqulwa, kwaye ikhetha kakhulu i-FGFR2 inhibitor.

Ithagethi: FGFR2